MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.14811

Медицинская библиотека · Anticancer research · 2021

The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells.

Conrad David M, Hilchie Ashley L, McMillan Katelyn A M, Liwski Robert S, Hoskin David W, Power Coombs Melanie R

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIM: Hepcidin is a cationic acute phase reactant synthesized by the liver. It has bactericidal properties and is a major regulator of iron homeostasis. Cationic antimicrobial peptides represent an innate antimicrobial defense system. We hypothesized that, like other cationic antimicrobial peptides, hepcidin is cytotoxic to cancer cells.

MATERIALS AND

METHODS

The cytotoxicity of human hepcidin against myeloma cells was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and DNA fragmentation assays. Plasma membrane damage was quantified by propidium iodide (PI) staining. Cell membrane changes were visualized by scanning electron microscopy.

RESULTS

Hepcidin impaired myeloma cell survival and induced DNA fragmentation. PI staining and scanning electron microscopy revealed hepcidin-induced disruption of the plasma membrane.

CONCLUSION

Human hepcidin is an anti-cancer peptide that induces myeloma cell lysis, and therefore may play a role in innate anticancer immunity. To our knowledge, this is the first biological function ascribed to human hepcidin that is not related to its antimicrobial and iron-regulatory properties.

Для цитирования: Conrad David M, Hilchie Ashley L, McMillan Katelyn A M, Liwski Robert S, Hoskin David W, Power Coombs Melanie R. The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells.. Anticancer research. 2021. DOI: 10.21873/anticanres.14811.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.